NCT01732848View on ClinicalTrials.gov

A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)

CompletedOBSERVATIONAL
Enrollment

113

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
HealthyHepatitis C
Interventions
DRUG

BMS-986094/INX-08189

DRUG

Placebo matching BMS-986094/INX-08189

Trial Locations (5)

37920

New Orleans Center For Clinical Research - Knoxville, Knoxville

55114

Prism Research, Saint Paul

78215

Local Institution, San Antonio

90036

Local Institution, Los Angeles

00927

Local Institution, San Juan

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01732848 - A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189) | Biotech Hunter | Biotech Hunter